Aptinyx Inc. APTX
0.10 USD 0.00 (+0.00%)
Dec 29, 2023, 3:59 PM EST
0.09 Day range 0.096
0.009 52-week range 0.72
News
newsfilecorp.com Apotex Health Corp. (APTX) Opens the Market Toronto, Ontario--(Newsfile Corp. - June 11, 2026) - Jeff Watson, President and Chief Executive Officer, Apotex Health Corp. (Apotex) (TSX: APTX) along with its Board of Directors, executive team,…
businesswire.com Tentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEO SAN DIEGO--(BUSINESS WIRE)--Tentarix Biotherapeutics today announced the appointment of Andrew Kidd, MD, as chief executive officer. Mr. Kidd joins Tentarix with a distinguished career of over two…
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 93 stocks made new 52-week lows.
businesswire.com Aptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic Alternatives EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX) today reported recent business updates and financial results for the fourth quarter and full year 2022. Recent Business Updates In March,…
zacks.com Here's Why Aptinyx Inc. (APTX) Is a Great 'Buy the Bottom' Stock Now After losing some value lately, a hammer chart pattern has been formed for Aptinyx Inc. (APTX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate…
zacks.com COYA, Dr. Reddy's Sign Deal for Proposed Abatacept Biosimilar COYA and Dr. Reddy's enter into a license agreement where the latter will source proposed biosimilar of abatacept biosimilar to Coya to develop and commercialize COYA 302.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 479 stocks made new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 116 companies set new 52-week lows.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023 
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 100 stocks hit new 52-week lows.- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday, 79 stocks hit new 52-week lows.
benzinga.com Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early…
investorplace.com Why Is Aptinyx (APTX) Stock Down 64% Today? Aptinyx (NASDAQ: APTX ) stock is taking a beating on Tuesday after the company revealed results from a Phase 2 clinical trial. The bad news here is that this clinical trial failed to meet its primary…
benzinga.com Why Catalyst Biosciences Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket Gainers Catalyst Biosciences Inc (NASDAQ: CBIO) rose 105% to $0.49 in pre-market trading. South Korea's GC Biopharma said it has signed an asset purchase agreement with Catalyst Biosciences to…
businesswire.com Aptinyx Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies and Provides Pipeline and Corporate Update EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders,…
businesswire.com Aptinyx to Present at the SVB Securities Global Biopharma Conference EVANSTON, Ill.--( BUSINESS WIRE )--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders,…- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
businesswire.com Preclinical Data from Aptinyx's NMDA Receptor Modulators to be Presented at the 52nd Annual Meeting of the Society for Neuroscience EVANSTON, Ill.
seekingalpha.com Aptinyx Inc. (APTX) CEO Andy Kidd on Q3 2022 Results - Earnings Call Transcript Aptinyx Inc. (NASDAQ:APTX ) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Patrick Flavin - Senior Manager, Corporate Development & IR Andy Kidd - President and CEO…
businesswire.com Aptinyx Reports Third Quarter 2022 Financial Results and Recent Highlights EVANSTON, Ill.
benzinga.com Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday Gainers- benzinga.com Earnings Scheduled For November 8, 2022 Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
businesswire.com Clinical Evaluation of Aptinyx's NYX-783 for Treatment of Opioid Use Disorder to Be Funded by $5.6 Million NIH Grant EVANSTON, Ill.- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday morning, 446 companies hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Thursday Thursday saw 177 companies set new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 200 companies hit new 52-week lows.
businesswire.com Aptinyx to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022 EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders,…
businesswire.com Aptinyx to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022 EVANSTON, Ill.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 838 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's trading, 528 companies set new 52-week lows.
businesswire.com Aptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders,…- benzinga.com Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.
benzinga.com Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year.
zacks.com Aptinyx's (APTX) Mid-Stage Fibromyalgia Study Fails to Meet Goal Aptinyx (APTX) reports disappointing data from a mid-stage study assessing NYX-2925 for the treatment of fibromyalgia. Stocks decline
businesswire.com Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Fibromyalgia EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders,…- benzinga.com Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.
- benzinga.com Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6…
seekingalpha.com Aptinyx Inc. (APTX) CEO Andy Kidd on Q2 2022 Results - Earnings Call Transcript Aptinyx Inc. (NASDAQ:APTX ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Patrick Flavin - Senior Manager, Corporate Development & Investor Relations Andy Kidd -…
businesswire.com Aptinyx Reports Second Quarter 2022 Financial Results and Recent Highlights EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders,…- benzinga.com Earnings Scheduled For August 4, 2022 Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
businesswire.com Aptinyx to Report Second Quarter 2022 Financial Results on Thursday, August 4, 2022 EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders,…- benzinga.com This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
- benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's trading, 69 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 215 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For May 12, 2022 Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.
- benzinga.com 90 Biggest Movers From Yesterday Gainers
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday, 849 stocks hit new 52-week lows.
- benzinga.com 53 Biggest Movers From Yesterday Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average…
- benzinga.com 28 Stocks Moving in Wednesday's Pre-Market Session Gainers Guardion Health Sciences, Inc. (NASDAQ: GHSI) rose 46.4% to $0.4098 in pre-market trading after jumping around 48% on Tuesday. Guardion Health Sciences recently reported closing of $11…